Trifluridine (also called trifluorothymidine or TFT) is an anti-herpesvirus antiviral drug, used primarily on the eye. It was sold under the trade name, Viroptic, by Glaxo Wellcome, now merged into GlaxoSmithKline. The brand is now owned by Monarch Pharmaceuticals, which is wholly owned by King Pharmaceuticals.
Chemical Properties
Physical Appearance
A solid
Storage
Store at -20°C
M.Wt
296.2
Cas No.
70-00-8
Formula
C10H11F3N2O5
Solubility
≥14.45 mg/mL in DMSO; ≥17.03 mg/mL in EtOH with ultrasonic; ≥3.72 mg/mL in H2O with ultrasonic